Send me a link:

*Text messaging rates may apply.

 Dow Down0.19% Nasdaq Up0.45%

AstraZeneca PLC (AZN)

-NYSE
73.19 Up 0.08(0.11%) 4:00PM EDT
|After Hours : 73.50 Up 0.31 (0.42%) 7:10PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 25,711,000   27,973,000   33,591,000  
Cost of Revenue5,261,000  5,393,000  6,026,000  
Gross Profit 20,450,000   22,580,000   27,565,000  
Operating Expenses
Research Development4,821,000  5,243,000  5,523,000  
Selling General and Administrative11,917,000  9,189,000  10,730,000  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 3,712,000   8,148,000   12,795,000  
Income from Continuing Operations
Total Other Income/Expenses Net50,000  42,000  1,533,000  
Earnings Before Interest And Taxes3,762,000  8,190,000  12,845,000  
Interest Expense495,000  544,000  562,000  
Income Before Tax3,267,000  7,646,000  12,283,000  
Income Tax Expense696,000  1,376,000  2,333,000  
Minority Interest -   -   -  
Net Income From Continuing Ops2,571,000  6,270,000  9,950,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 2,571,000   6,270,000   9,950,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 2,571,000   6,270,000   9,950,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.